| A cross-platform toolkit for mass spectrometry and proteomics MC Chambers, B Maclean, R Burke, D Amodei, DL Ruderman, ... Nature biotechnology 30 (10), 918-920, 2012 | 3140 | 2012 |
| ProteoWizard: open source software for rapid proteomics tools development D Kessner, M Chambers, R Burke, D Agus, P Mallick Bioinformatics 24 (21), 2534-2536, 2008 | 1922 | 2008 |
| Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth DB Agus, RW Akita, WD Fox, GD Lewis, B Higgins, PI Pisacane, ... Cancer cell 2 (2), 127-137, 2002 | 1098 | 2002 |
| Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo LM Butler, DB Agus, HI Scher, B Higgins, A Rose, C Cordon-Cardo, ... Cancer research 60 (18), 5165-5170, 2000 | 827 | 2000 |
| 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/neu and Inhibits the Growth of Prostate Cancer Xenografts DB Solit, FF Zheng, M Drobnjak, PN Münster, B Higgins, D Verbel, ... Clinical cancer research 8 (5), 986-993, 2002 | 559 | 2002 |
| Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer DB Agus, MS Gordon, C Taylor, RB Natale, B Karlan, DS Mendelson, ... Journal of clinical oncology 23 (11), 2534-2543, 2005 | 503 | 2005 |
| Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. DB Agus, SS Gambhir, WM Pardridge, C Spielholz, J Baselga, JC Vera, ... The Journal of clinical investigation 100 (11), 2842-2848, 1997 | 419 | 1997 |
| Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non … CH Moskowitz, JR Bertino, JR Glassman, EE Hedrick, S Hunte, ... Journal of clinical oncology 17 (12), 3776-3785, 1999 | 391 | 1999 |
| Reentry of T cells to the adult thymus is restricted to activated T cells. DB Agus, CD Surh, J Sprent The Journal of experimental medicine 173 (5), 1039-1046, 1991 | 320 | 1991 |
| Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence DB Agus, C Cordon-Cardo, W Fox, M Drobnjak, A Koff, DW Golde, ... Journal of the National Cancer Institute 91 (21), 1869-1876, 1999 | 308 | 1999 |
| Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse SM Henshall, DEH Afar, J Hiller, LG Horvath, DI Quinn, KK Rasiah, K Gish, ... Cancer research 63 (14), 4196-4203, 2003 | 293 | 2003 |
| Dehydroascorbic acid, a blood–brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke J Huang, DB Agus, CJ Winfree, S Kiss, WJ Mack, RA McTaggart, ... Proceedings of the National Academy of Sciences 98 (20), 11720-11724, 2001 | 291 | 2001 |
| Stromal cell oxidation: a mechanism by which tumors obtain vitamin C DB Agus, JC Vera, DW Golde Cancer research 59 (18), 4555-4558, 1999 | 262 | 1999 |
| Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific … HI Scher, M Eisenberger, AV D'Amico, S Halabi, EJ Small, M Morris, ... Journal of Clinical Oncology 22 (3), 537-556, 2004 | 236 | 2004 |
| Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R LC Amler, DB Agus, C LeDuc, ML Sapinoso, WD Fox, S Kern, D Lee, ... Cancer research 60 (21), 6134-6141, 2000 | 204 | 2000 |
| HER-2/neu (p185neu) Protein Expression in the Natural or Treated History of Prostate Cancer I Osman, HI Scher, M Drobnjak, D Verbel, M Morris, D Agus, JS Ross, ... Clinical Cancer Research 7 (9), 2643-2647, 2001 | 200 | 2001 |
| Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors CM Robbins, WA Tembe, A Baker, S Sinari, TY Moses, ... Genome research 21 (1), 47-55, 2011 | 198 | 2011 |
| Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and-independent human xenograft models DB Agus, HI Scher, B Higgins, WD Fox, G Heller, M Fazzari, ... Cancer Research 59 (19), 4761-4764, 1999 | 194 | 1999 |
| Future cancer research priorities in the USA: a Lancet Oncology Commission EM Jaffee, C Van Dang, DB Agus, BM Alexander, KC Anderson, ... The Lancet Oncology 18 (11), e653-e706, 2017 | 191 | 2017 |
| CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom’s macroglobulinemia SP Treon, DB Agus, B Link, G Rodrigues, A Molina, MQ Lacy, DC Fisher, ... Journal of immunotherapy 24 (3), 272-279, 2001 | 176 | 2001 |
